These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22203431)

  • 21. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease.
    Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P
    Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
    Phillips RJ; Lokmic Z; Crock CM; Penington A
    J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study.
    Tiwari P; Pandey V; Gangopadhyay AN; Sharma SP; Gupta DK
    Oral Maxillofac Surg; 2016 Mar; 20(1):73-7. PubMed ID: 26481918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution.
    Itinteang T; Brasch HD; Tan ST; Day DJ
    J Plast Reconstr Aesthet Surg; 2011 Jun; 64(6):759-65. PubMed ID: 20870476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of propanolol for treatment of infantile haemangioma.
    Andersen IG; Rechnitzer C; Charabi B
    Dan Med J; 2014 Feb; 61(2):A4776. PubMed ID: 24495884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of propranolol to treat multicentric airway haemangioma.
    Mistry N; Tzifa K
    J Laryngol Otol; 2010 Dec; 124(12):1329-32. PubMed ID: 20370949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring propranolol treatment in periocular infantile haemangioma.
    Burne R; Taylor R;
    Eye (Lond); 2014 Nov; 28(11):1281-4; quiz 1285. PubMed ID: 25323853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children.
    Wasilewska AM; Zoch-Zwierz WM
    Pediatr Nephrol; 2008 Oct; 23(10):1795-802. PubMed ID: 18594870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifocal infantile haemangioma: a diagnostic challenge.
    Torres E; Rosa J; Leaute-Labreze C; Soares-de-Almeida L
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27317759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus.
    Yürük Yıldırım Z; Yılmaz A; Pehlivanoğlu C; Gedikbaşı A; Yıldız M; Dirican A; Bundak R; Darendeliler F; Emre S; Nayır A
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):157-163. PubMed ID: 30396876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose propranolol regimen for infantile haemangioma.
    Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
    J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol as an effective therapy for infantile haemangioma of the urinary bladder.
    Anwar T; Malm-Buatsi E
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30709884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
    de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
    J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
    Storch CH; Hoeger PH
    Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature.
    Oksiuta M; Matuszczak E; Debek W; Dzienis-Koronkiewicz E; Hermanowicz A
    J Matern Fetal Neonatal Med; 2016; 29(1):64-8. PubMed ID: 25385271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol.
    Campanelli R; Codazzi AC; Poletto V; Abbà C; Catarsi P; Fois G; Avanzini MA; Brazzelli V; Tzialla C; De Silvestri A; Tinelli C; Licari A; Berra-Romani R; Zuccolo E; Moccia F; Mannarino S; Rosti V; Massa M
    Thromb Haemost; 2019 Feb; 119(2):274-284. PubMed ID: 30609443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
    Schneider M; Cremer HJ; Ruef P
    Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.